Department of Diabetes and Endocrinology, Guy's and St Thomas' Hospital NHS Trust, London, UK.
Department of Diabetes and Endocrinology, King's College London, London, UK.
Clin Endocrinol (Oxf). 2020 Aug;93(2):87-96. doi: 10.1111/cen.14250. Epub 2020 Jun 15.
There are limited recommendations for fasting in many chronic diseases such as adrenal insufficiency (AI). Research in such situations highlights potential for complications and need for education for patients with AI undertaking fasting during Ramadan. This article aimed to provide up-to-date guidance for healthcare professionals to educate, discuss and manage patients with AI who are considering fasting in Ramadan and is religiously compatible. Latest guidance on this topic and the evidence base for steroid dosing are reviewed and discussed. Risk stratification for patients with AI and optimal strategies for management, including steroid dosing, are detailed. Our review highlights that patients with AI wishing to fast should undergo a thorough risk assessment ideally several months before Ramadan. 'High risk' and 'Very high risk' patients should be encouraged to explore alternative options to fasting discussed below. Prior to the commencement of Ramadan, all patients must receive up-to-date education on sick day rules, instructions on when to terminate their fast or abstain from fasting, carry steroid warning information and must have a valid intramuscular (IM) hydrocortisone pack and know how to administer this. Switching patients with AI desiring to fast from multiple daily hydrocortisone replacement to prednisolone 5 mg once daily at dawn (during Suhoor or Sehri) is recommended and discussed. Patients on fludrocortisone for AI should be advised to take their total dose at dawn. We provide practically relevant case-based scenarios to help with the application of this guidance. Future efforts need to focus on healthcare professional awareness and further research in this setting.
在许多慢性疾病中,如肾上腺功能不全 (AI),禁食的建议有限。在这种情况下的研究强调了潜在的并发症,并需要对在斋月期间禁食的 AI 患者进行教育。本文旨在为医疗保健专业人员提供最新的指导,以教育、讨论和管理考虑在斋月期间进行且与宗教信仰兼容的 AI 患者禁食。审查和讨论了关于这一主题的最新指南和类固醇剂量的证据基础。详细介绍了 AI 患者的风险分层和最佳管理策略,包括类固醇剂量。我们的综述强调,希望禁食的 AI 患者应进行彻底的风险评估,理想情况下应在斋月前几个月进行。应鼓励“高风险”和“极高风险”患者探索以下讨论的替代禁食方案。在斋月开始之前,所有患者都必须接受关于生病日规则的最新教育,有关何时终止禁食或避免禁食的说明,携带类固醇警示信息,并且必须拥有有效的肌内 (IM) 氢化可的松包,并知道如何使用。建议并讨论将希望禁食的 AI 患者从每日多次氢化可的松替代治疗转换为清晨(在 Suhoor 或 Sehri 期间)一次服用 5 毫克泼尼松龙。应建议接受 AI 用氟氢可的松治疗的患者在清晨服用其总剂量。我们提供了实际相关的案例场景,以帮助应用此指南。未来的工作需要侧重于医疗保健专业人员的意识和在此环境中的进一步研究。